Effectiveness and Safety of Paclitaxel-Coated Balloon Angioplasty for Coronary Small Vessel Disease

Overview

This study evaluates the efficacy and safety of a paclitaxel-coated balloon for treating coronary small vessel disease (SVD) and very small vessel disease (VSVD). Results indicate that the paclitaxel-coated balloon may reduce late lumen loss compared to conventional treatments.

Background

Coronary small vessel disease poses significant challenges in treatment due to limited luminal gain from stent implantation. Drug-coated balloons (DCB) have emerged as a promising alternative, particularly in patients at high risk of complications from stenting. Understanding the efficacy of DCB in SVD is crucial for improving patient outcomes.

Data Highlights

No numerical data provided in the source material.

Key Findings

• The study was a multicenter, randomized controlled trial evaluating a paclitaxel-coated balloon.
• Patients with RVD between ≥ 1.50 mm and ≤ 2.50 mm were included, with a subset defined as VSVD.
• In-lesion late lumen loss (LLL) was the primary endpoint, assessed at 9 months post-procedure.
• DCB showed a trend toward improved safety compared to drug-eluting stents, with lower rates of in-stent thrombosis and myocardial infarction.
• DCB is increasingly recommended as a treatment option for SVD globally.

Clinical Implications

The findings support the use of paclitaxel-coated balloons as a viable treatment for patients with small vessel disease, particularly in those at risk for complications from stenting. Clinicians should consider DCB as a first-line option in appropriate patient populations.

Conclusion

The study highlights the potential of paclitaxel-coated balloons in managing coronary small vessel disease, suggesting a shift in treatment strategies towards less invasive options.

Related Resources & Content

1. Author(s)/Org, Source, Year -- Title
2. Author(s)/Org, Source, Year -- Title
3. Author(s)/Org, Source, Year -- Title
4. Author(s)/Org, Source, Year -- Title
5. Guideline Document, ESC, 2024 -- ESC Chronic Coronary Syndromes Guideline
6. Author(s)/Org, Source, Year -- Title
7. American College of Cardiology, ACC, 2024 -- Drug-Coated Balloon Angioplasty with Rescue Stenting
8. https://icus-society.org/wp-content/uploads/2024/09/ESCCCS-2024-guideline7.pdf
9. https://academic.oup.com/eurheartj/article/46/17/1586/8029575
10. Drug-Coated Balloon Angioplasty With Rescue Stenting Versus Intended Stenting for the Treatment of Patients With de Novo Coronary Artery Lesions - American College of Cardiology